Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Eisai, Biogen discontinue clinical studies on AD drug candidate

biospectrumasiaSeptember 16, 2019

Tag: Eisai , Biogen , AD drug candidate

PharmaSources Customer Service